Business Context and Reporting Period
This Form 8-K is filed by Cyclacel Pharmaceuticals, Inc. (not Bio Green Med Solution, Inc.) on August 14, 2013. The filing serves to announce financial results for the second quarter ended June 30, 2013. The company is incorporated in Delaware and maintains its principal executive offices in Berkeley Heights, NJ.
Key Financial Metrics
The filing text provided is a cover sheet and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These details are referenced as being contained in the attached press release (Exhibit 99.1), which is not included in the source text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only indicates that a press release announcing these results is attached as Exhibit 99.1.
Guidance, Outlook, and Management Commentary
Management has scheduled a conference call to review the financial results on August 14, 2013, at 4:30 p.m. Eastern Time. The filing explicitly states that the information regarding results of operations and financial condition is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference into other filings, except as expressly set forth by specific reference.
Important Facts for Investor Verification
- Verify the specific financial figures (revenue, net loss, cash position) in the attached Exhibit 99.1 press release, as they are absent from this cover document.
- Confirm the company name is Cyclacel Pharmaceuticals, Inc., noting the discrepancy with the "Bio Green Med Solution, Inc." label in the request metadata.
- Review the conference call transcript or recording from August 14, 2013, for management's commentary on the Q2 2013 results.
- Note that the financial data in this 8-K is not legally "filed" under Section 18 of the Exchange Act, which may affect liability protections for the statements.